Pembrolizumab‐induced sarcoid granulomatous panniculitis and bullous pemphigoid in a single patient

Pembrolizumab is an immune checkpoint inhibitor with antitumor activity in other organ malignancies. We present this case —demonstrating multiple inflammatory adverse events associated with Pembrolizumab (in a single patient), in order to increase awareness and facilitate earlier identification of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Honigman, Anthony D., Lai, Francis, Elakis, Joshua, Prall, Owen, Goh, Michelle, McCormack, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452463/
https://www.ncbi.nlm.nih.gov/pubmed/30997084
http://dx.doi.org/10.1002/ccr3.2090
_version_ 1783409293788184576
author Honigman, Anthony D.
Lai, Francis
Elakis, Joshua
Prall, Owen
Goh, Michelle
McCormack, Christopher
author_facet Honigman, Anthony D.
Lai, Francis
Elakis, Joshua
Prall, Owen
Goh, Michelle
McCormack, Christopher
author_sort Honigman, Anthony D.
collection PubMed
description Pembrolizumab is an immune checkpoint inhibitor with antitumor activity in other organ malignancies. We present this case —demonstrating multiple inflammatory adverse events associated with Pembrolizumab (in a single patient), in order to increase awareness and facilitate earlier identification of the wide‐ranging cutaneous side effects associated with immunotherapy.
format Online
Article
Text
id pubmed-6452463
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-64524632019-04-17 Pembrolizumab‐induced sarcoid granulomatous panniculitis and bullous pemphigoid in a single patient Honigman, Anthony D. Lai, Francis Elakis, Joshua Prall, Owen Goh, Michelle McCormack, Christopher Clin Case Rep Case Reports Pembrolizumab is an immune checkpoint inhibitor with antitumor activity in other organ malignancies. We present this case —demonstrating multiple inflammatory adverse events associated with Pembrolizumab (in a single patient), in order to increase awareness and facilitate earlier identification of the wide‐ranging cutaneous side effects associated with immunotherapy. John Wiley and Sons Inc. 2019-03-11 /pmc/articles/PMC6452463/ /pubmed/30997084 http://dx.doi.org/10.1002/ccr3.2090 Text en © 2019 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Honigman, Anthony D.
Lai, Francis
Elakis, Joshua
Prall, Owen
Goh, Michelle
McCormack, Christopher
Pembrolizumab‐induced sarcoid granulomatous panniculitis and bullous pemphigoid in a single patient
title Pembrolizumab‐induced sarcoid granulomatous panniculitis and bullous pemphigoid in a single patient
title_full Pembrolizumab‐induced sarcoid granulomatous panniculitis and bullous pemphigoid in a single patient
title_fullStr Pembrolizumab‐induced sarcoid granulomatous panniculitis and bullous pemphigoid in a single patient
title_full_unstemmed Pembrolizumab‐induced sarcoid granulomatous panniculitis and bullous pemphigoid in a single patient
title_short Pembrolizumab‐induced sarcoid granulomatous panniculitis and bullous pemphigoid in a single patient
title_sort pembrolizumab‐induced sarcoid granulomatous panniculitis and bullous pemphigoid in a single patient
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452463/
https://www.ncbi.nlm.nih.gov/pubmed/30997084
http://dx.doi.org/10.1002/ccr3.2090
work_keys_str_mv AT honigmananthonyd pembrolizumabinducedsarcoidgranulomatouspanniculitisandbullouspemphigoidinasinglepatient
AT laifrancis pembrolizumabinducedsarcoidgranulomatouspanniculitisandbullouspemphigoidinasinglepatient
AT elakisjoshua pembrolizumabinducedsarcoidgranulomatouspanniculitisandbullouspemphigoidinasinglepatient
AT prallowen pembrolizumabinducedsarcoidgranulomatouspanniculitisandbullouspemphigoidinasinglepatient
AT gohmichelle pembrolizumabinducedsarcoidgranulomatouspanniculitisandbullouspemphigoidinasinglepatient
AT mccormackchristopher pembrolizumabinducedsarcoidgranulomatouspanniculitisandbullouspemphigoidinasinglepatient

Ejemplares similares